SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $40,000 | -66.1% | 154,013 | -68.7% | 0.00% | – |
| Q1 2016 | $118,000 | -31.8% | 491,446 | +0.2% | 0.00% | – |
| Q4 2015 | $173,000 | -82.3% | 490,446 | -12.5% | 0.00% | – |
| Q3 2015 | $976,000 | -38.5% | 560,793 | -21.2% | 0.00% | – |
| Q2 2015 | $1,587,000 | +48.5% | 712,009 | +29.2% | 0.00% | – |
| Q1 2015 | $1,069,000 | -8.8% | 551,119 | +24.7% | 0.00% | – |
| Q4 2014 | $1,172,000 | -27.6% | 442,111 | -17.8% | 0.00% | – |
| Q3 2014 | $1,619,000 | -39.0% | 537,583 | -17.2% | 0.00% | – |
| Q2 2014 | $2,656,000 | +108.0% | 649,640 | +119.2% | 0.00% | – |
| Q1 2014 | $1,277,000 | -11.0% | 296,390 | +8.2% | 0.00% | – |
| Q4 2013 | $1,435,000 | -54.8% | 273,856 | -45.6% | 0.00% | – |
| Q3 2013 | $3,178,000 | +187.3% | 503,822 | +127.3% | 0.00% | – |
| Q2 2013 | $1,106,000 | – | 221,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,058,136 | $71,893,000 | 85.78% |
| ARMISTICE CAPITAL, LLC | 3,240,000 | $6,286,000 | 2.79% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 738,748 | $1,433,000 | 0.26% |
| Geller Advisors LLC | 187,323 | $363,000 | 0.21% |
| Verity Asset Management, Inc. | 56,518 | $110,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 334,713 | $649,000 | 0.08% |
| Cutler Capital Management, LLC | 72,500 | $140,000 | 0.06% |
| BLUE ARROW CAPITAL MANAGEMENT LLC | 199,930 | $388,000 | 0.04% |
| Jefferies Group LLC | 3,240,000 | $6,286,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 399,000 | $794,000 | 0.03% |